UNSPSC 51183610: Insulin glargine

This classification denotes a therapeutic insulin with the molecular formula C267H404N72O78S6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2ZM8CX04RZ, chemically known as insulin (ox), 8a-l-threonine-10a-l-isoleucine-30b-l-threonine- but more generally known as insulin, which bears US NIH Compound Identifier 16129672. European Medicines Agency schedules Insulin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB02689MIG.

UNSPSC 51183610 Insulin glargine, a Commodity code, describes a specific pharmaceutical product — a long-acting basal insulin used to treat type 1 and type 2 diabetes — that state and local health agencies, school districts, and public employee benefit programs procure for beneficiaries and patients. The code covers insulin glargine formulations regardless of brand or manufacturer, and state and local buyers typically source through competitive bidding, group purchasing agreements, or existing pharmaceutical contracts to manage cost and ensure supply continuity. Purchasing entities include state Medicaid programs, state health departments, county public health agencies, and school districts that maintain student health and medication services. The product moves through established pharmaceutical distribution channels with pricing and contract terms negotiated at the state or regional cooperative level rather than individual transactions.

The source provides no recent state and local contract opportunities tagged to UNSPSC 51183610. Activity under this code is likely captured within broader pharmaceutical procurement vehicles — state Medicaid omnibus contracts, county health services contracts, or school district health and safety provisions — rather than as standalone commodity solicitations. Business development professionals pursuing insulin glargine sales to state and local entities should monitor general pharmaceutical RFPs and state health agency procurement notices, and focus on group purchasing organization (GPO) enrollment, state formulary inclusion, and Medicaid contracting as primary channels rather than discrete UNSPSC-51183610 bid opportunities.